McNulty Alana B.
Insider CIK 1606086 · JANX Director · EFTR Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 11,667 | — | $0 | 11,667 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2025-06-11 | 2025-06-13 | 3,750 | — | $0 | 6,250 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 8,350 | — | $0 | 8,350 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2024-06-26 | 2024-06-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-06-20 | 2022-06-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2022-01-20 | 2022-01-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2021-09-07 | 2021-09-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 96,570 | — | $0 | 96,570 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 65,185 | — | $0 | 65,185 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 96,570 | — | $0 | 96,570 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 43,456 | — | $0 | 43,456 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 113,470 | — | $0 | 113,470 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 120,713 | — | $0 | 120,713 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 38,628 | — | $0 | 38,628 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-08-25 | 2021-08-27 | 91,826 | — | $0 | 91,826 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award | 2021-08-25 | 2021-08-27 | 48,768 | — | $0 | 48,768 | SEC↗ |